NASDAQ$BTTC

Black Titan Corp · Q1 2017 earnings

Q1 2017 earnings · Reported May 10, 2017 (9 years ago) · Investor relations

May 10Mar 31, 2017

Total Revenue

$40K

No prior period

EPS (adj)

-$576.00

Previous: -$324.00-77.8%

Capital Expenditures

$26K

Previous: $57K-54.4%

Free Cash Flow

-$3.14M

No prior period

Net Income

-$3.01M

Previous: -$1.85M-62.8%

Operating Income

-$3.44M

Previous: -$1.83M-87.7%

Gross Profit

-$2.09M

No prior period

Cash & Equivalents

$10.9M

Previous: $5.76M+88.6%

Total Assets

$13.1M

Previous: $12M+9.0%

Stock-Based Comp

$421K

Previous: $332K+26.8%

Titan Pharmaceuticals · Revenue · Quarterly

$40K

Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation